Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: October 7, 2024
Context: The filing serves to incorporate by reference a press release regarding the presentation of the Company's ProSense® technology at the 2024 European Society of Breast Imaging (EUSOBI) Conference.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is a current report focused on a specific corporate event rather than a periodic financial statement.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The primary update is the dissemination of clinical data regarding the ProSense® system.
Guidance, Outlook, and Management Commentary
- Clinical Milestone: Icecure's ProSense® was featured in six global studies on the cryoablation of breast tumors presented at the EUSOBI 2024 conference.
- Regulatory Action: The press release, including the summary of the six abstracts and the "Forward Looking Statements" section, is incorporated by reference into the Company's Registration Statements on Form F-3 and Form S-8.
- Management Commentary: The filing does not contain direct management commentary beyond the incorporation of the press release text.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) to review the specific details of the six global studies.
- Review the "Forward Looking Statements" section within the incorporated press release for potential risks and assumptions.
- Confirm the impact of these clinical presentations on the Company's regulatory strategy for breast tumor cryoablation.
- Check subsequent filings for any updates to the Registration Statements (Form F-3 and Form S-8) referenced in this report.